Modification of carbon nanotube's dispersion using cetyltrimethyl ammonium bromide (CTAB) as cancer drug delivery

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

1 Citation (Scopus)

Abstract

Cancer is a disease that causes many deaths globally. Cancer treatments have side effects that can danger the human body. Carbon nanotube (CNT) becomes drug (anti-cancer) delivery towards cancer cells that have been targeted. Yet, CNT tends to aggregate. It could be overcome by functionalization (modification) of CNT using Cetyltrimethyl Ammonium Bromide (CTAB). The variations we use were CNT-CTAB with a dose of CNT 100 mg and CTAB varied between 80, 90, 100, 110, and 120 mg. There were several stages of CNT modification process: dispersion, filtration, washing, and drying. The optimum condition obtained was on CNT-110 mg CTAB because it could be dispersed up to 70 hours better than pure CNT, Zeta Potential (ZP) ≥16 mV, and absorbance Uv-vis 1.05. Both the ZP value and the absorbance of Uv-vis showed the CNT dispersion modified to be better than the pure CNT. Furthermore, SEM-EDX did not produce structural damage to CNT modified surfaces, the percentage of the mass of Oxygen (O) elements as characteristic of increased hydrophilic properties, and Ni elements as toxic impurities become reduced. FTIR spectrum results showed the highest intensity occurred at CTAB CNT-110mg at 1221 m-1. This strong C-N vibration interaction suggests that CNTs CNT modification become readily dispersed in water.

Original languageEnglish
Title of host publication2nd Biomedical Engineering�s Recent Progress in Biomaterials, Drugs Development, and Medical Devices
Subtitle of host publicationProceedings of the International Symposium of Biomedical Engineering, ISBE 2017
EditorsRadon Dhelika, Yudan Whulanza, Ghiska Ramahdita, Praswasti P.D.K. Wulan
PublisherAmerican Institute of Physics Inc.
ISBN (Electronic)9780735416253
DOIs
Publication statusPublished - 13 Feb 2018
Event2nd Biomedical Engineering's Recent Progress in Biomaterials, Drugs Development, and Medical Devices, ISBE 2017 - Bali, Indonesia
Duration: 25 Jul 201726 Jul 2017

Publication series

NameAIP Conference Proceedings
Volume1933
ISSN (Print)0094-243X
ISSN (Electronic)1551-7616

Conference

Conference2nd Biomedical Engineering's Recent Progress in Biomaterials, Drugs Development, and Medical Devices, ISBE 2017
CountryIndonesia
CityBali
Period25/07/1726/07/17

Keywords

  • CNT
  • CTAB
  • dispersion
  • modification

Fingerprint Dive into the research topics of 'Modification of carbon nanotube's dispersion using cetyltrimethyl ammonium bromide (CTAB) as cancer drug delivery'. Together they form a unique fingerprint.

Cite this